title: Clinicopathological features and the value of differential Cytokeratin 7 and 20 expression in resolving diagnostic dilemmas of ovarian involvement by colorectal adenocarcinoma and vice-versa.
abstract: The distinction between metastasis from a colorectal adenocarcinoma into the ovary and an ovarian adenocarcinoma is vital, but challenging at times, due to overlapping morphological features. Similarly, a distinction between an ovarian metastasis into the colorectum and a colorectal adenocarcinoma, although rare; is important and can be daunting. We report an analysis of 20 cases of ovarian involvement by metastatic colorectal adenocarcinomas and colorectal involvement by metastatic ovarian adenocarcinomas, including the value of differential expression of cytokeratins 7 & 20 by immunohistochemistry (IHC), in these cases. Nine cases (45%) were identified as colorectal adenocarcinomas metastatic to the ovary. On biopsy, all these cases showed a 'garland-like' tumor necrosis, with desmoplasia and predominantly exhibited a tubuloalveolar pattern (67% cases). On IHC, all 8 of 9 such cases, where staining for cytokeratin 20 was performed, displayed strong positivity and 7 cases, where staining for carcinoembryogenic antigen (CEA) was performed, revealed positivity for this marker (100%). Other 11 cases (55%) were ovarian adenocarcinomas, metastatic to the colorectum. These showed metachronous presentations, with the ovarian tumor preceding the colorectal tumor deposits. Morphologically, psammomatous calcification was noted in 73% of these cases, whereas 'garland-like' necrosis was absent in all. The chief morphological subtype was serous papillary cystadenocarcinoma (55% cases). On IHC, CK7 and CA 125 were positive in all 6 of 11 such cases, whereas CK 20 was negative in all these cases.In cases of complex presentations like an ovarian involvement by a metastatic colorectal adenocarcinoma and vice-versa, certain clinicopathological features are useful. Differential expression of CK 7 and CK20 is vital in resolving these dilemmas. CK20 positivity and CK7 negativity is associated with a colorectal adenocarcinoma. Markers like CEA and CA-125 have an added value.
authors.affiliation: Department of Pathology, Tata Memorial Hospital, Mumbai, India. rekhi.bharat@gmail.com
authors.forename: Bharat
authors.initials: B
authors.lastname: Rekhi
authors.forename: Sophia
authors.initials: S
authors.lastname: George
authors.forename: Bhulaxmi
authors.initials: B
authors.lastname: Madur
authors.forename: R F
authors.initials: RF
authors.lastname: Chinoy
authors.forename: Rajesh
authors.initials: R
authors.lastname: Dikshit
authors.forename: Amita
authors.initials: A
authors.lastname: Maheshwari
references.citation: Dis Colon Rectum. 1998 Oct;41(10):1312-4; discussion 1314-5
references.pmid: 9788396
references.citation: Am J Clin Pathol. 2002 Jun;117(6):944-51
references.pmid: 12047147
references.citation: Gynecol Oncol. 2006 Apr;101(1):97-101
references.pmid: 16278010
references.citation: Cancer. 1989 Oct 1;64(7):1508-13
references.pmid: 2776109
references.citation: Hum Pathol. 2002 Nov;33(11):1078-85
references.pmid: 12454811
references.citation: Semin Diagn Pathol. 2005 Feb;22(1):3-32
references.pmid: 16512597
references.citation: Am J Surg Pathol. 2006 Feb;30(2):177-84
references.pmid: 16434891
references.citation: Gynecol Oncol. 1995 Nov;59(2):200-6
references.pmid: 7590473
references.citation: Am J Clin Pathol. 1992 Jun;97(6):751-8
references.pmid: 1595595
references.citation: Histopathology. 2005 Sep;47(3):231-47
references.pmid: 16115224
references.citation: Am J Pathol. 1990 Mar;136(3):641-55
references.pmid: 1690512
references.citation: Hum Pathol. 1998 May;29(5):491-7
references.pmid: 9596273
references.citation: Am J Pathol. 1992 Feb;140(2):427-47
references.pmid: 1371204
references.citation: J Clin Oncol. 1997 Jan;15(1):368-81
references.pmid: 8996164
references.citation: Jpn J Clin Oncol. 1997 Jun;27(3):193-6
references.pmid: 9255277
references.citation: Am J Surg Pathol. 1987 Feb;11(2):114-21
references.pmid: 3812871
references.citation: Gynecol Oncol. 2004 Sep;94(3):850-3
references.pmid: 15350388
references.citation: Am J Surg Pathol. 2006 Sep;30(9):1130-9
references.pmid: 16931958